Jump to content
News 247

Panacea Biotec gets $20 million loan from US government for hexavalent vaccine capacity expansion

Author

By Author
in Health News

 Share

Recommended Posts

  • Author
Author Newbie

Author 0

Posted
  • Author
Posted
Panacea Biotec has secured a $20 million long-term loan from the US International Development Finance Corporation to expand its hexavalent vaccine production. This funding will help the company meet global demand for childhood immunization, supplying vaccines to UN agencies. The hexavalent vaccine, EasySix, protects against six diseases and is expected to see significant demand growth by 2030.

Source Link


View full article

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
 Share
Go to topic listing
×
×
  • Create New...

Important Information

Cookie Consent & Terms We use cookies to enhance your experience on our site. By continuing to browse our website, you agree to our use of cookies as outlined in our We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.. Please review our Terms of Use, Privacy Policy, and Guidelines for more information.